Dr. Usmani

Prof. Dr. Khalida Usmani M.D., Lahore, Pakistan

Born in the city of Lahore in Pakistan, Dr. Usmani studied medicine in her hometown, in the USA and in England. After graduation she worked in London until in 1971 she joined the Fatima Jinnah Medical College in Lahore as Assistant Professor of Surgery. In 1977 she was promoted as Associate Professor and became Professor of Surgery in 1980. Then, in 1996, she became the head of the department of Surgery and only two years later became Principal of the Medical College.
Dr. Usmani founded and was Executive Director of the Cancer Research Foundation of Pakistan. She is president of the World Institute of Ecology and Cancer (Asian Chair).

Prof. Usmani received a number of national and international awards for her work and gave influential presentations the world over. In 1997 she started a long term study on the therapy of breast cancer patients after surgery with the intake of EM-X. At the conference she will present the development and latest results of this important study.

---

Presentation
Sunday, September 10th, 2006 / 11:00 –11:20

Postoperative treatment of breast cancer patients with EM-X

In most developed countries, breast cancer is the most frequent and leading cause of cancer death in women. In Pakistan, during the past two decades, the incidence of breast cancer has increased steeply. The patients present with breast cancer at an earlier age as compared to the west.

A prospective study on the role of oral EM-X in the management of breast cancer patients is being carried out for the last ten years. It includes all stages of breast cancer in a wide age range of women.
The patients get the multi-modality treatment for breast cancer which includes surgery, chemotherapy, radiotherapy and hormone therapy as is practiced all over the word.

EM-X has been a valuable addition since 1997. EM-X is started from day one before surgery.
We have noticed a marked difference in the group of patients who were given EM-X from day one. It made a vast difference to the vitality, feelings of well being, the survival time and quality of life of breast cancer patients, especially in advanced breast cancer cases the symptoms of bone pains, breathlessness and appetite. There were no pyogenic or fungal infections in patients taking EM-X.

EM-X has made a significant difference in adding life to the days rather than adding days to the life of the patients.

Keywords: EM-X, breast cancer, post-operative treatment